High dose rate brachytherapy for carcinoma of the cervix: Risk factors for late rectal complications

被引:22
作者
Uno, T
Itami, J
Aruga, M
Kotaka, K
Fujimoto, H
Sato, T
Minoura, S
Ito, H
机构
[1] Int Med Ctr, Dept Radiat Therapy & Oncol, Shinjuku Ku, Tokyo 162, Japan
[2] Int Med Ctr, Dept Gynecol, Shinjuku Ku, Tokyo 162, Japan
[3] Chiba Univ, Sch Med, Dept Radiol, Chiba 280, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1998年 / 40卷 / 03期
关键词
carcinoma of uterine cervix; radiation therapy; high dose rate brachytherapy; complications; isodose volume;
D O I
10.1016/S0360-3016(97)00849-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine the incidence of late rectal complications in patients treated with high dose rate brachytherapy for FIGO Stage IIB, IIIB carcinoma of the uterine cenix, and to evaluate the treatment factors associated with an increased probability of treatment complications. Methods and Materials: Records of 100 patients with FIGO IIB and IIIB cervical carcinoma treated with definitive irradiation using high dose rate intracavitary brachytherapy (HDR-ICR) between 1977 and 1994 mere retrospectively reviewed. For each HDR-ICR session, 6-Gy isodose volume was reconstructed retrospectively and the relationship between probability of late rectal complications and several treatment factors, including a specific point dose and parameters representing isodose volume, were examined. Statistical analyses were performed to determine the treatment factors predictive of late rectal complications. Results: Of patients treated for both stages, 33% and 38% had experienced moderate to severe (Grade 2-4) complications at 3 and 5 years, respectively, Mean value of depth (L)) of 6-Gy isodose volume in HDR-ICR in patients with and without complication were 51 mm and 46 mm, respectively (p = 0.0070), A significant difference was noted in complication rate between patients with D > 51 mm and D less than or equal to 51 mm (p = 0.0023), Cumulative Point S (2 cm dorsal from the midpoint of the ovoid sources) dose (p = 0.044), and single or total point S dose by HDR-ICR (p = 0.019, each) mere significantly higher in patients who developed complication, whereas these factors did not significantly affect the probability of pelvic control. Multivariate analysis revealed that D was the independent predictor for the endpoint of actuarial complication rate (p = 0.047), No significant difference was noted in the product of L, D, and IV value (L x D x W) between patients with less than Grade 2 rectal complication and those with Grade 2-4. Conclusion: Depth of 6-Gy isodose volume determined three dimensionally (3D) has the predictive value of late rectal complications, This suggests that the shape of the high dose area in HDR-ICR influences the incidence of late rectal complications regardless of its volume. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 50 条
[21]   Treatment results and prognostic factors in inoperable carcinoma of the cervix treated with external plus high dose brachytherapy [J].
Garipagaoglu, M ;
Yalvac, S ;
Kose, MF ;
Tulunay, G ;
Kayikcioglu, F ;
Çakmak, A ;
Haberal, A ;
Boran, N ;
Adli, M ;
Hayran, M .
CANCER LETTERS, 1999, 136 (01) :17-26
[22]   From low-dose-rate to high-dose-rate brachytherapy in lip carcinoma: Equivalent results but fewer complications [J].
Guinot, Jose-Luis ;
Arribas, Leoncio ;
Isabel Tortajada, Maria ;
Crispin, Vicente ;
Carrascosa, Maria ;
Santos, Miguel ;
Mut, Alejandro ;
Bosco Vendrell, Juan ;
Pesudo, Carmen ;
Luisa Chust, Maria .
BRACHYTHERAPY, 2013, 12 (06) :528-534
[23]   Treatment Outcome of Medium-Dose-Rate Intracavitary Brachytherapy for Carcinoma of the Uterine Cervix: Comparison With Low-Dose-Rate Intracavitary Brachytherapy [J].
Kaneyasu, Yuko ;
Kita, Midori ;
Okawa, Tomohiko ;
Maebayashi, Katsuya ;
Kohno, Mari ;
Sonoda, Tatsuo ;
Hirabayashi, Hisae ;
Nagata, Yasushi ;
Mitsuhashi, Norio .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (01) :137-145
[24]   Dosimetric analysis of the effects of the bladder volume on organs at risk (OAR) in high-dose-rate intracavitary brachytherapy in carcinoma cervix an institutional study [J].
Das Sharma, Ashutosh ;
Poddar, Jyoti ;
Suryanarayan K, U. ;
Shah, Sonal Patel ;
Parikh, Ankita ;
Mehta, Vimesh ;
Kumar, Tarun .
JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2018, 10 (01) :26-31
[25]   The variance of bladder and rectal doses calculated from orthogonal and simple stereo films in cervix high-dose-rate brachytherapy [J].
Harris, Tracy ;
Hunter, Robert J. ;
Skoczny, Jack ;
Farrell, Thomas .
BRACHYTHERAPY, 2007, 6 (04) :304-310
[26]   High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer [J].
Liu, Ruifeng ;
Wang, XiaoHu ;
Tian, Jin Hui ;
Yang, KeHu ;
Wang, Jun ;
Jiang, Lei ;
Hao, Xiang Yong .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (10)
[27]   High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer [J].
Wang, XiaoHu ;
Liu, Ruifeng ;
Ma, Bin ;
Yang, KeHu ;
Tian, Jinhui ;
Jiang, Lei ;
Bai, Zheng Gang ;
Hao, Xiang Yong ;
Wang, Jun ;
Li, Jun ;
Sun, Shao Liang ;
Yin, Hong .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (07)
[28]   Palliation of advanced/recurrent esophageal carcinoma with high-dose-rate brachytherapy [J].
Sharma, V ;
Mahantshetty, U ;
Dinshaw, KA ;
Deshpande, R ;
Sharma, S .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (02) :310-315
[29]   Lack of the Dose-Rate Effect of 192Ir Source Activity on Pelvic Control and Late Complications After High-Dose-Rate Brachytherapy for Cervical Cancer [J].
Chen, Shang-Wen ;
Liang, Ji-An ;
Shiau, An-Chang ;
Yu, Chun-Yen ;
Hung, Yao-Ching ;
Yeh, Lian-Shung ;
Chang, Wei-Chun ;
Lin, Wu-Chou ;
Yang, Shih-Neng ;
Lin, Fang-Jen .
JOURNAL OF RADIATION RESEARCH, 2010, 51 (02) :173-179
[30]   Long-term results of high-dose rate intracavitary brachytherapy for squamous cell carcinoma of the uterine cervix [J].
Nakano, T ;
Kato, S ;
Ohno, T ;
Tsujii, H ;
Sato, S ;
Fukuhisa, K ;
Arai, T .
CANCER, 2005, 103 (01) :92-101